• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Solution Center
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Solution Center
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Reducing the Risk of Comparator Sourcing

    Clinical Data Management

    Leveraging AI/ML Analytics for Better Clinical Development Decisions

    What is a Manufacturing Ecosystem and Why are They Growing?

    Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins

    RK Pharma to Receive $200M Investment from PAG

    Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    TMC Expands Executive Team

    Peli BioThermal Opens Cold Chain Network Station in Southern California
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins

    RK Pharma to Receive $200M Investment from PAG

    Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    Peli BioThermal Opens Cold Chain Network Station in Southern California

    Purolite Expands Bioprocessing Production Capacity with New U.S. Facility
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Peli BioThermal Opens Cold Chain Network Station in Southern California

    Biocair Partners with TrakCel to Improve Visibility in the Supply Chain

    SpectronRx, RLS Partner to Boost Radiopharmaceutical Pipeline and Supply Chain

    Serialization and the War on Counterfeit Drugs

    Traceability & 2D Barcodes
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    RK Pharma to Receive $200M Investment from PAG

    Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease

    Almac Group Global Workforce Hits 7,000 Employees

    Amarna Therapeutics Names Henk Streefkerk CEO

    Trinity Life Sciences Names Leslie Orne CEO
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Regulatory Affairs: Accelerating Drug Development Timelines

    Berkshire Sterile Secures Over $230,000 in Training Grants

    Purification – A Bottleneck for Large-Scale Manufacturing of Oligonucleotide API?

    FDA 2023 Inspection Roadmap: Is “Readiness” in Your Annual Objectives?

    FDA Watch: Are You Suitably Staffed?
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Lannett CDMO

    Almac Group

    Syngene International Ltd.

    CMC Pharmaceuticals

    U.S. Pharmacopeia (USP)
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Lannett CDMO

    Almac Group

    Syngene International Ltd.

    CMC Pharmaceuticals

    U.S. Pharmacopeia (USP)
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • White Papers
    • Podcasts
    • Infographics
    • Microsites
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    5 Steps to Achieve a Successful Drug Product Launch

    Proven process to optimize commercial readiness.

    5 Steps to Achieve a Successful Drug Product Launch
    5 Steps to Achieve a Successful Drug Product Launch
    In the kickoff meetings all relevant stakeholders get involved. ©Vetter
    5 Steps to Achieve a Successful Drug Product Launch
    5-step-process of launch management at Vetter. ©Vetter
    Dr. Anna Schamberger and Sabrina Schumacher, Vetter04.04.23
    Bringing a new drug product to market can be a major challenge when it comes to guiding the late-stage development through to commercial readiness and launch. In fact, this is often considered one of the most impactful milestones of any drug program, because it culminates years of development work. It is usually during late-stage development, where there is a mindset shift from developing a drug product to commercializing it. Since timing is a crucial factor, decisive and focused launch management is required and involves a dedicated and experienced team to coordinate all necessary process steps. A successful first commercial production can be achieved in a predetermined timeline by following a thorough step-by-step approach.

    The biopharma product launch landscape is very diverse, and as such, the needs of each product to reach the market can vary significantly. To effectively establish a plan for launch management, the contract development and manufacturing organization (CDMO) partner needs to work closely with the customer to decide on the product-specific process. Part of the launch is designing a tried-and-true methodology to meet the specific needs of each molecule to bring both, a small batch as well as a blockbuster drug to market. Throughout the launch management process, the team is working against the launch date with the intentions to follow the best product implementation strategy for commercial market supply.

    Generally, when customers prepare for launch, they have already been collaborating with a CDMO partner and have an assigned project manager who helps guide their drug product through clinical development. When the launch management process begins, customers are paired with a launch manager, in addition to their project manager, to guide them through the journey to commercial production. At this point, the project manager assumes a new role within the launch team, and the launch manager takes the lead. The customer has access to both, the project and launch teams throughout the journey to commercial readiness. Though the managers will support the seamless step-by-step approach, external factors such as material or active pharmaceutical ingredient (API) supply must be closely monitored to avoid challenges that may arise and are outside the control of the service provider and customer.

    Transparency and open communication on risks and active management of expectations are paramount to make sure all parties involved agree on each process steps. A proven step-by-step approach contributes significant value to achieving market launch on time and allows the customer and partner to keep track of several activities running in parallel, preventing overlooked gaps or missed milestones.

    Initiation – Define Launch Process and Timeline

    The launch management process is initiated based on the customers product launch plan. This phase allows both parties to define the organizational structure as well as the requirements and expectations for the timeline to bring the product to market. With large teams from various departments such as quality control, demand management and supply chain management involved in the process, it is important to identify the roles and responsibilities of each member. This applies to the filling partner as well as the customer launch teams.

    Launch Kickoff – Initiate Product Handover to Commercial Team

    The kickoff follows the start of product transfer from project to commercial. This phase includes internal and external kickoff meetings to get all relevant stakeholders involved in the process. During the latter, the service provider introduces the launch management process and provides a full project and product overview to the launch teams. The customer in turn provides a full overview on their final product set up for commercial and their understanding of launch management. This is also when project manager, launch manager and customer will align on milestones, common goals, timelines, and identify risk factors. Once the project manager hands the lead over to the launch manager, they confirm a joint understanding of the overall approach, the future commercial working frame, and the supply chain management process. Assuming there is agreement on the communication and core team setup, the kickoff is complete.

    Launch Phase – Establish Commercial Set-Up

    During the launch phase, a filling partner will establish a methodical way of working with the team including both internal and external players. This step also includes gaps and opening actions within a launch checklist developed in collaboration with the customer. Progress made throughout the launch phase is tracked during the regular meetings both internally, within the CDMO, and externally with the customer, to maintain open lines of communication. It is common during this phase to evaluate both best-case and worst-case forecasts to correspond with the planning of the launch and to develop corresponding scenarios to support flexible handling of the process throughout.

    In an effort to conduct commercial setup, the launch management team will allocate process topics e.g. the API allocation, setup primary packaging, management supply, API storage and clean room equipment to match the customer’s forecasting needs and logistics process. Throughout commercial setup, there is an overall awareness of the anticipated timeline and processes, as well as dependencies on both the CDMO and the customer. As the process goes on and milestones are met, action items on the launch checklist are checked off. If there are any risks, whether related to supply chain, packaging, or otherwise, that might delay launch, they are flagged in this phase of the process.

    Launch Batches – Manufacturing First Commercial Batch

    This phase marks the completion of product transfer from project to commercial teams and the execution of the first commercial fill within the pre-planned scenario. Most of the defined activities must be completed by the launch tracker such as packaging material availability, personnel training and adherence of correct shipping processes and requirements. Also, all necessary orders are placed, and the availability of crucial components are confirmed.

    Post-Launch – Commercial Manufacturing and Project Close Down

    Following the successful release of the first launch batch, a formal close-down of the project commences. The CDMO team will collect lessons-learned and feedback from the customer to optimize execution of future launches. Learning occurs on both sides - the customer learns how to better get their products to launch, and the filling partner learns how to further improve its launch management process.

    Once a launch batch of the drug product is released, the formal close-down within the system is complete and the project manager and project team are released. At this point, the product has made its way through the launch management process and is now in the hands of the commercial team. The commercial team will remain responsible for continuous process verification, monitoring key performance indicators and yield data, forecasting and capacity reservation for medication, participating in business review and quality management review meetings, and managing the future lifecycle activities of the product. 


    Dr. Anna Schamberger has more than 10 years of experience in the pharmaceutical industry, primarily working with CDMOs. After joining Vetter in 2016, she began in customer project management leading late-stage drug product and life cycle projects. Since 2020, Dr. Schamberger has been a director in customer project management, leading a team of eight project managers. She is also a program manager for strategic partnerships, overlooking and leading product portfolio and supports multiple key strategic and operational activities within Vetter’s customer project management, achieving customer goals to commercialize innovative and life-saving products for a global market.

    Sabrina Schumacher has 15 years of experience at Vetter and over seven years of experience as a customer relations manager, leading several launches for various customers in the function of a launch manager. She supports customers as a central contact and knowledge carrier within the company and develops solutions to complex challenges throughout the commercial development phase. Since 2020, she has been the team lead for customer service, leading a team of nine customer service representatives.
      Loading, Please Wait..
      Trending
      • SpectronRx, RLS Partner To Boost Radiopharmaceutical Pipeline And Supply Chain
      • Samsung Biologics Accelerates Timeline Of New Fifth Plant
      • Biopharma Layoffs In 1Q23
      • Veeva Business Consulting Expands With New R&D Services
      • CRO Industry Trends & Challenges
      Breaking News
      • EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins
      • RK Pharma to Receive $200M Investment from PAG
      • Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
      • TMC Expands Executive Team
      • Peli BioThermal Opens Cold Chain Network Station in Southern California
      View Breaking News >
      CURRENT ISSUE

      May 2023

      • New Modalities Hog the Limelight
      • Cell and Gene Therapy is Coming of Age
      • Demand Surges for Cell and Gene Therapy Contract Manufacturing
      • Embracing a New Reality
      • Japan: A Unique Opportunity for Regenerative Medicines and Cell & Gene Therapies
      • Single-Use Technologies Enable Biologic Scaling
      • Get Smart: Integrating PAT Data into Existing Biotech Data Infrastructures
      • FTEs in Drug Discovery
      • Digital Transformation in Pharma
      • What is a Manufacturing Ecosystem and Why are They Growing?
      • View More >

      Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
      You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

      • About Us
      • Privacy Policy
      • Terms And Conditions
      • Contact Us

      follow us

      Subscribe
      Nutraceuticals World

      Latest Breaking News From Nutraceuticals World

      Sempera Organics and Alkemist Labs Announce Partnership for Mushroom Testing
      Nektium Expands International Distribution Network for Botanical Extracts
      Kemin Receives Positive EFSA Opinion for BetaVia Pure, its Beta-Glucan Ingredient
      Coatings World

      Latest Breaking News From Coatings World

      PPG’s New Paint for a New Start Initiative to Beautify Schools Worldwide with Colorful Makeovers
      Powder Technology, Inc. Announces New Electrical Coating
      Michelman Chosen as Inaugural Recipient of Innovation Research Interchange (IRI) Excellence Award
      Medical Product Outsourcing

      Latest Breaking News From Medical Product Outsourcing

      Cue Health Nabs FDA's First De Novo Nod for an At-Home COVID Test
      ISO 13485:2016 Certification Granted to Boston BioProducts
      Paul Colvin Joins Ora Inc. as Chief Operating Officer
      Contract Pharma

      Latest Breaking News From Contract Pharma

      EUROAPI Invests €50M to Meet Growing Demand for Prostaglandins
      RK Pharma to Receive $200M Investment from PAG
      Axol Bioscience, StrataStem Partner on ‘Clinical Trial in a Dish’ for Alzheimer’s Disease
      Beauty Packaging

      Latest Breaking News From Beauty Packaging

      Estée Lauder Announces Second Edition of Beauty&You Brand Incubator Program
      GetHarley Raises $52 Million in Latest Funding Round
      Refillable Skincare Products Face Hurdles Despite Growing Sustainability Awareness
      Happi

      Latest Breaking News From Happi

      Carrière Frères Introduces Candle Refills as New Sustainability Initiative
      Gen Z Entrepreneur Introduces The Ashley Marie Collection for 4C Hair Types
      The Estée Lauder Companies Expands Beauty&You Competition for Indian Beauty Brands
      Ink World

      Latest Breaking News From Ink World

      Siegwerk’s Center of Excellence in France Receives Facelift
      Epson announces MakeTheSwitch Campaign
      Pigments Market to Reach $26,598 Million by 2022: AMR
      Label & Narrow Web

      Latest Breaking News From Label & Narrow Web

      Mark Andy reports successful Low Migration Workshop
      Ryback and Ryback Consulting launches Machinery division
      TLMI launches 2023 award programs
      Nonwovens Industry

      Latest Breaking News From Nonwovens Industry

      The Honest Company to Exit Europe, Asia
      TechnoPlants to Exhibit at ITMA
      Andritz Buys 100% Stake in Dan-Web
      Orthopedic Design & Technology

      Latest Breaking News From Orthopedic Design & Technology

      Orthobiologics Market to Top $10.3 Billion by 2030
      Artelon Granted U.S. FDA 510(k) Clearance for FlexBand, FlexPatch & FlexBand Plus
      Synergy Spine Solutions Completes Enrollment in IDE Clinical Trial
      Printed Electronics Now

      Latest Breaking News From Printed Electronics Now

      ASSA ABLOY Receives Clearance from Mexico for HHI Acquisition
      Christoph Ostermann Named Chairman of Heliatek‘s Advisory Board
      Flexible and Printed Electronics Represented at productronica 2023

      Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

      AD BLOCKER DETECTED

      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker.


      FREE SUBSCRIPTION Already a subscriber? Login